Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15

scientific article published on 02 June 2018

Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ORET.2018.04.009
P932PMC publication ID6261277
P698PubMed publication ID30506012

P50authorEmily ChewQ24266614
Amitha DomalpallyQ42716579
P2093author name stringR P Danis
B A Blodi
Age-Related Eye Disease Study 2 (AREDS2) Research Group
R Trane
T E Clemons
P2860cites workRanibizumab and bevacizumab for neovascular age-related macular degenerationQ24616209
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospectsQ26774188
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsQ28049700
Ranibizumab for neovascular age-related macular degenerationQ29617549
The prevalence of age-related macular degeneration and associated risk factorsQ33957918
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy.Q34081266
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.Q34652928
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17Q34653094
Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trialsQ35214092
Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.Q35601906
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)Q35780510
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments TrialsQ35897354
Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab TreatmentQ35960504
PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.Q36004881
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments TrialsQ36247080
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Q36360812
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)Q36996217
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trialsQ39830867
Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.Q39848356
Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.Q40467797
The Wisconsin age-related maculopathy grading systemQ41902806
Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.Q42716529
Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP studyQ46247369
Causes and prevalence of visual impairment among adults in the United StatesQ46890945
MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION.Q49488840
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.Q52886344
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEAL MICROVASCULATURE IN GEOGRAPHIC ATROPHY.Q53047129
Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular DegenerationQ88345802
P433issue10
P921main subjecteye diseaseQ3041498
macular degenerationQ27429789
P304page(s)1021-1027
P577publication date2018-06-02
P1433published inOphthalmology RetinaQ63241478
P1476titleAtrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15
P478volume2

Reverse relations

Q92456774A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part IIcites workP2860

Search more.